EC Ophthalmology

Purpose: The classification of primary angle-closure glaucoma (PSG) on the basis of genetic studies is proposed.

Methods: 30 patients (46 eyes) aged 40 to 65 years with various forms of angle-closure glaucoma were examined.

Results: Clinical and genetic analysis of patients with primary angle-closure glaucoma was carried out. It is noted that the classification based on biometric indicators does not take into account the genetic characteristics of patients with PACG, predisposition to which is inherent at birth. Indications for preventive laser iridectomy with appositional closure of the anterior chamber angle are substantiated.

Conclusion: The innate nature of PACG dictates the need for the formation of a pathogenetic classification of PACG.

Keywords: Primary Angle-Closure Glaucoma; Classification; Genetic Polymorphisms

1. European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 2: Classification and Terminology Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 2 Classification and Terminology British Journal of Ophthalmology5 (2017): 73-127.
2. Foster PJ., et al. “The definition and classification of glaucoma in prevalence surveys”. British Journal of Ophthalmology2 (2002): 238-242.
3. Do T., et al. “Ultrasound Biomicroscopic Diagnosis of Angle- closure Mechanisms in Vietnamese Subjects with Unilateral Angle-closure Glaucoma”. Journal of Glaucoma2 (2018): 115-120.
4. Nesterov AP. “Glaucoma”. Moscow: Medical information Agency (2008).
5. Ritch R. “Exfoliation syndrome and occludable angles”. Transactions of the American Ophthalmological Society 92 (1994): 845-944.
6. Weener ME., et al. “Genetic testing of ocular manifestations of proliferative syndrome to provide pathophysiology-oriented treatment”. Russian Journal of Clinical Ophthalmology1 (2022): 16-22.
7. Lee S., et al. “NGSCheckMate: software for validating sample identity in next-generation sequencing studies within and across data types”. Nucleic Acids Research11 (2017): 103.
8. Ermolaev AP. “On the connection of the primary manifestations of angle-closure glaucoma with the appearance of posterior vitreous detachment”. Bulletin of Ophthalmology2 (2013): 23-27.
9. Nongpiur ME., et al. “ABCC5, a gene that influences the anterior chamber depth, is associated with primary angle closure glaucoma”. PLOS Genetics3 (2014): e1004089.
10. Awadalla MS., et al. “Association of genetic variants with primary angle closure glaucoma in two different populations”. PLOS ONE 8 (2013): 67903.
11. Chung C., et al. “Correlation of iris collagen and in-vivo anterior segment structures in patients in different stages of chronic primary angle-closure in both eyes”. Indian Journal of Ophthalmology10 (2019): 1638-1644.
12. Seet LF., et al. “Distinct iris gene expression profiles of primary angle closure glaucoma and primary open angle glaucoma and their interaction with ocular biometric parameters”. Clinical and Experimental Ophthalmology 44 (2016): 684-692.
13. Haer-Wigman L., et al. “Diagnostic exome sequencing in 266 Dutch patients with visual impairment”. European Journal of Human Genetics 25 (2017): 591-599.
14. Y Chen., et al. “Extended association study of PLEKHA7 and COL11A1 with primary angle closure glaucoma in a han chinese population”. Investigative Ophthalmology and Visual Science 55 (2014): 3797-3802.
15. Zhong Y., et al. “Flat Anterior Chamber after Trabeculectomy in Secondary Angle-Closure Glaucoma with BEST1 Gene Mutation: Case Series”. PLoS ONE1 (2017): e0169395.
16. Vithana EN., et al. “Genome-wide association Analyses identify three new susceptibility loci for primary angle closure glaucoma”. Nature Genetics 44 (2012): 1142-1146.
17. Zhuang W., et al. “Genotype-ocular biometry correlation analysis of eight primary angle closure glaucoma susceptibility loci in a cohort from Northern China”. PLoS ONE 11(2018): e0206935.
18. MS Awadalla., et al. “Matrix metalloproteinase-9 genetic variation and primary angle closure glaucoma in a Caucasian population”. Molecular Vision 17 (2011): 1420-1424.
19. Micheal S., et al. “Polymorphisms in matrix metalloproteinases MMP1 and MMP9 are associated with primary open angle and angle closure glaucoma in a Pakistani population”. Molecular Vision 19 (2013): 441-447.
20. Evans DR., et al. “A novel pathogenic missense ADAMTS17 variant that impairs secretion causes Weill-Marchesani Syndrome with variably dysmorphic hand features”. Scientific Reports1 (2020): 10827.
21. AS Khokhlova., et al. “The role of the matrix metalloproteinase system in the progression of primary open-angle glaucoma”. Pacific Medical Journal 2 (2017): 32-34.
22. Sundin OH., et al. “Extreme hyperopia is the result of null mutations in MFRP, which encodes a Frizzled-related protein”. Proceedings of the National Academy of Sciences of the United States of America27 (2005): 9553-9558.
23. Pauer GJ., et al. “Mutation screen of the membrane- type frizzled-related protein (MFRP) gene in patients with inherited retinal degenerations”. Ophthalmic Genetics4 (2005): 157-161.
24. Beletskaya IS and Astakhov SYu. “The role of matrix metalloproteinases in glaucoma pathogenesis”. Oftal'mologicheskie Vedomosti3 (2015): 28-43.
25. Zueva MV. “Dynamics of retinal ganglion cell death in glaucoma and its functional markers”. National Journal Glaucoma1 (2016): 70-85.
26. Bakunina NA., et al. “Vascular and vegetative factors of glaucoma attack”. Russian Ophthalmological Journal4 (2021): 22-30.
27. Nesterov AP. “Glaukoma”. М.: Medicine (2014).
28. Chencova OB., et al. “Optimization of diagnosis and treatment of primary and secondary glaucoma”. Al'manah Klinicheskoj Mediciny 3 (2000): 109-114.
29. Bakunina NA., et al. “A method for reducing the formation of scar tissue after non-penetrating deep sclerectomy”. Glaucoma 1 (2009): 3-6.